US FDA Awards Fast Track Designation (FTD) to Paxalisib for Gl...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, Aug. 20, 2020/PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalis...
Authors: LATEST ASIANET NEWS RELEASES